ID
32813
Description
Study ID: 107085 Clinical Study ID: GLP107085 Study Title: A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01406262 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2
Keywords
Versions (1)
- 11/16/18 11/16/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 16, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
The Effect of Albiglutide on Cardiac Repolarisation Compared with Placebo 107085
Day 35: Vital Signs
- StudyEvent: ODM
Description
Vital Signs
Description
Vital Signs Date
Data type
date
Description
Vital Signs Time
Data type
time
Description
Blood Pressure Systolic
Data type
integer
Measurement units
- mmHg
Description
Blood Pressure Diastolic
Data type
integer
Measurement units
- mmHg
Description
Pulse
Data type
integer
Measurement units
- bpm
Description
Temperature
Data type
float
Measurement units
- °C
Description
e.g., Sitting
Data type
text
Description
Comment
Data type
text
Similar models
Day 35: Vital Signs
- StudyEvent: ODM
No comments